These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10082661)

  • 21. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
    Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors.
    Bawadi HA; Antunes TM; Shih F; Losso JN
    J Agric Food Chem; 2004 Jul; 52(15):4730-6. PubMed ID: 15264907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.
    Ntayi C; Lorimier S; Berthier-Vergnes O; Hornebeck W; Bernard P
    Exp Cell Res; 2001 Oct; 270(1):110-8. PubMed ID: 11597133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic trypsin activates human promatrix metalloproteinase-2.
    Lindstad RI; Sylte I; Mikalsen SO; Seglen PO; Berg E; Winberg JO
    J Mol Biol; 2005 Jul; 350(4):682-98. PubMed ID: 15950241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
    Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tissue factor pathway inhibitor-2 in cancer biology.
    Sierko E; Wojtukiewicz MZ; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin).
    Nagase H; Suzuki K; Enghild JJ; Salvesen G
    Biomed Biochim Acta; 1991; 50(4-6):749-54. PubMed ID: 1666284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of type IV procollagenases by human tumor-associated trypsin-2.
    Sorsa T; Salo T; Koivunen E; Tyynelä J; Konttinen YT; Bergmann U; Tuuttila A; Niemi E; Teronen O; Heikkilä P; Tschesche H; Leinonen J; Osman S; Stenman UH
    J Biol Chem; 1997 Aug; 272(34):21067-74. PubMed ID: 9261109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, function and biology of tissue factor pathway inhibitor-2.
    Chand HS; Foster DC; Kisiel W
    Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xanthine oxidase activates pro-matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells through non-free radical mechanisms.
    Liu W; Rosenberg GA; Shi H; Furuichi T; Timmins GS; Cunningham LA; Liu KJ
    Arch Biochem Biophys; 2004 Jun; 426(1):11-7. PubMed ID: 15130778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.
    Saunders WB; Bayless KJ; Davis GE
    J Cell Sci; 2005 May; 118(Pt 10):2325-40. PubMed ID: 15870107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE crosslinkage of Fcepsilon receptor I induces both production and activation of matrix metalloproteinase-9 in mast cells.
    Tanaka A; Matsuda H
    Cell Immunol; 2004 Mar; 228(1):66-75. PubMed ID: 15203321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
    J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.